- Home
- SOL vs ELUT Comparison
SOL vs ELUT Comparison
Compare SOL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- ELUT
- Stock Information
- Founded
- SOL 2005
- ELUT 2015
- Country
- SOL United States
- ELUT United States
- Employees
- SOL N/A
- ELUT N/A
- Industry
- SOL Semiconductors
- ELUT Medical Specialities
- Sector
- SOL Technology
- ELUT Health Care
- Exchange
- SOL Nasdaq
- ELUT Nasdaq
- Market Cap
- SOL 97.4M
- ELUT 145.2M
- IPO Year
- SOL 2008
- ELUT 2020
- Fundamental
- Price
- SOL $1.83
- ELUT $4.84
- Analyst Decision
- SOL Buy
- ELUT Strong Buy
- Analyst Count
- SOL 3
- ELUT 2
- Target Price
- SOL $3.83
- ELUT $10.00
- AVG Volume (30 Days)
- SOL 212.0K
- ELUT 48.8K
- Earning Date
- SOL 11-14-2024
- ELUT 11-14-2024
- Dividend Yield
- SOL N/A
- ELUT N/A
- EPS Growth
- SOL N/A
- ELUT N/A
- EPS
- SOL N/A
- ELUT N/A
- Revenue
- SOL $102,489,000.00
- ELUT $24,782,000.00
- Revenue This Year
- SOL N/A
- ELUT $8.00
- Revenue Next Year
- SOL $46.42
- ELUT $39.89
- P/E Ratio
- SOL N/A
- ELUT N/A
- Revenue Growth
- SOL 25.98
- ELUT N/A
- 52 Week Low
- SOL $1.41
- ELUT $1.96
- 52 Week High
- SOL $3.00
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- SOL 43.76
- ELUT 61.53
- Support Level
- SOL $1.75
- ELUT $3.30
- Resistance Level
- SOL $1.98
- ELUT $4.40
- Average True Range (ATR)
- SOL 0.13
- ELUT 0.45
- MACD
- SOL 0.01
- ELUT -0.02
- Stochastic Oscillator
- SOL 40.11
- ELUT 84.62
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.